Pancreatic Phospholipase A Activity in Duodenal Aspirates

1966 ◽  
Vol 1 (3) ◽  
pp. 228-231 ◽  
Author(s):  
Egil Gjone ◽  
Pål Bjørnstad ◽  
Per F. Marton ◽  
Otto M. Orning
Digestion ◽  
1989 ◽  
Vol 42 (3) ◽  
pp. 128-134 ◽  
Author(s):  
I. Nordback ◽  
O. Teerenhovi ◽  
O. Auvinen ◽  
T. Koivula ◽  
T. Thuren ◽  
...  

2001 ◽  
Vol 29 (2) ◽  
pp. 069-076 ◽  
Author(s):  
Makoto Motoyoshi ◽  
Masanori Sugiyama ◽  
Yutaka Atomi ◽  
Wataru Kimura ◽  
Hirokazu Nagawa

2001 ◽  
Vol 15 (10) ◽  
pp. 1834-1836 ◽  
Author(s):  
Asim K. Mandal ◽  
Zhongjian Zhang ◽  
Janice Y. Chou ◽  
Anil B. Mukherjee

1990 ◽  
Vol 68 (2) ◽  
pp. 579-585 ◽  
Author(s):  
G. N. Moll ◽  
H. J. Vial ◽  
E. M. Bevers ◽  
M. L. Ancelin ◽  
B. Roelofsen ◽  
...  

The transbilayer distribution of glycerophospholipids in the plasma membrane of Plasmodium knowlesi infected erythrocytes was studied by using lysine-116-ε-N-palmitoyl amidinated pancreatic phospholipase A2. As a consequence of its superior membrane penetrating capacities, this modified enzyme rapidly degrades its substrates in the outer membrane leaflet of intact erythrocytes, a property that makes the enzyme an excellent tool to study the malaria parasitized red cell. The modified phospholipase A2 caused a nonlytic hydrolysis of up to 12–15% of the phosphatidylethanolamine and none of the phosphatidylserine in the red cell membrane, irrespective of whether the cells harboured trophozoite and schizont stages of parasites or no parasites at all. The absence of phosphatidylserine at the exterior surface of Plasmodium infected erythrocytes was confirmed by applying the prothrombinase assay on Plasmodium falciparum infected human erythrocytes. Consequently, the results from these and previous studies indicate that the plasma membrane of Plasmodium infected erythrocytes exhibit a normal transbilayer phospholipid asymmetry.Key words: malaria, plasma membrane, phospholipid asymmetry, erythrocyte, prothrombinase assay.


1972 ◽  
Vol 28 (2) ◽  
pp. 156-160 ◽  
Author(s):  
Lambert H. M. Janssen ◽  
Simon H. Bruin ◽  
Gerard H. Haas

1995 ◽  
Vol 4 (1) ◽  
pp. 67-70 ◽  
Author(s):  
W. Pruzanski ◽  
B. P. Kennedy ◽  
H. van den Bosch ◽  
E. Stefanski ◽  
M. Wloch ◽  
...  

Tenidap (TD) was initially defined as a dual inhibitor of cyclooxygenase and lipoxygenase. This study was designed to assess its inhibitory activity against proinflammatory phospholipase A2. This study shows that TD inhibits the synthesis of pro-inflammatory secretory non-pancreatic phospholipase A2(sPLA2). Concentrations as low as 0.25 μg/ml (0.725 μM) reduced the release of sPLA2by 40% from foetal rat calvarial osteoblasts stimulated with IL-1β and TNFα, whereas a concentration of 2.5 μg/ml (7.25 μM) reduced the release by over 80%. TD also markedly reduced the release of sPLA2from unstimulated cells. There was no direct inhibition of sPLA2enzymatic activity by TDin vitro. Northern blot analysis showed that TD did not affect the sPLA2mRNA levels; however, immunoblotting showed a dose-dependent reduction in sPLA2enzyme. These results, together with a marked reduction in sPLA2enzymatic activity, suggest that TD inhibits sPLA2synthesis at the post-transcriptional level. Therefore TD seems to inhibit the arachidonic acid cascade proximally to cyclooxygenase and lipoxygenase and its anti-inflammatory activity may be related at least in part to the inhibition of sPLA2synthesis.


Sign in / Sign up

Export Citation Format

Share Document